Capillaroscopy is a dynamic process in mixed connective tissue disease

Lupus

Volumn 16, Issue 4, 2007, Pages 254-258

  De Holanda Mafaldo Diogenes A ^a   Bonfá, Eloisa ^a   Fuller, R ^a   Correia Caleiro, M T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Interstitial lung disease; Mixed connective tissue disease; Nailfold capillaroscopy

Indexed keywords

AUTOANTIBODY;

ADULT; ARTICLE; CAPILLAROSCOPY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SCLERODERMA;

ADULT; AGED; AUTOANTIBODIES; CAPILLARIES; FEMALE; HUMANS; LUNG; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; NAILS; SEVERITY OF ILLNESS INDEX;

EID: 34249049811     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307076517     Document Type: Article

References (36)

1. Cutolo M, Pizzorni C, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol 2005; 19: 437-452.
2. Maricq HR, Leroy EC. Capillary blood flow un scleroderma. Bibl Anat 1973; 11: 352-358.
3. Planchon B, Pistorius MA, Beurrier P, De Faucal P. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology 1994; 45: 677-686.
4. Mannarino E, Pasqualini L, Fedeli F, Scricciolo V, Innocente S. Nailfold capillaroscopy in the screening and diagnosis of Raynaud's phenomenon. Angiology, 1994; 45: 37-42.
5. Anders HJ, Sigl T, Schattenkirchner M. Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 2001; 60: 407-409.
6. Bredemeier M, Xavier RM, Capobianco K et al. Nailfold capillaroscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004; 31: 286-294.
7. Lovy M, MacCarter D, Steigerwald JC. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 1985; 28: 496-501.
8. Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease J Rheumatol 1986; 13: 556-563.
9. Chen ZY, Silver RM, Ainsworth SK, Dobson RL, Rust P, Maricq HR. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984; 77: 812-822.
10. Furtado RN, Pucinelli MI, Cristo VV, Andrade LE, Sato EI. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients. Lupus 2002; 11: 35-41.
11. Grader-Beck T, Wigley FM. Raynaud's phenomenon in mixed connective tissue disease. Rheum Dis Clin N Am 2005; 31: 465-481.
12. Bennett RM. Mixed connective tissue disease and others overlap syndrome. In Harris ED ed. Kelley's textbook of rheumatology, 7th ed. Elsevier, 2005: 1258-1278.
13. Granier F, Vayssairat M, Priollet P, Housset E. Nailfold capillaroscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum 1986; 29: 189-195.
14. Riccieri V, Spadaro A, Ceccarelli F, Scrivo R, Germano V, Valesini G. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus 2005; 14: 521-525.
15. Nussbaum AI, Silver RM, Maricq HR. Serial changes in nailfold capillary morphology in childhood dermatomyositis. Arthritis Rheum 1983; 26: 1169-1172.
16. Spencer-Green G, Crowe WE, Levinson JE. Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis. Arthritis Rheum 1982; 25: 954-958.
17. Sullivan WD, Hurst DJ, Harmon CE et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984; 63: 92-107
18. Maricq HR, Leroy EC, D'Angelo WA et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23: 183-189.
19. Maricq, HR. Wide field capillary microscopy. Techinique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24: 1159-1165.
20. Kasukawa R. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In Kasukawa R, Sharp GC eds. Mixed connective tissue disease and antinuclear antibodies. Elsevier, 1987: 41-47.
21. Tan EM, Peebles C. Quantification of antibodies to Sm antigen and nuclear ribonucleoprotein by hemagglutination. In Rose NR, Friedman H eds. Manual of clinical immunology, 2nd edn. Amer Soc Microbiol 1980; 866-870.
22. Andrade LEC, Gabriel A, Jr Assad RL, Ferrari AJL, Atra E. Panoramic nailfold capillaroscopy: A new reading method and normal range. Semin Art Rheum 1990; 20: 21-31.
23. Lee P, Leung FY-K, Alderdice C, Armstrong Sk. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 1983; 10: 930-938.
24. Maricq HR, Maize JC. Nailfold capillary abnormalities. Clin Rheum Dis 1982; 8: 455-478.
25. Bennett RM, O'Connell DJ. Mixed connective tisssue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum 1980; 10: 25-51.
26. Lundberg IE. The prognosis of mixed connective tissue disease. Rheum Dis Clin N Am 2005; 31: 535-547.
27. Maricq HR, Spencer-Green G, Leroy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976; 61: 862-870.
28. Bodolay E, Szekanecz Z, Dévényi K et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology 2005 (Rheumatology Advance Access published 16 February 2005).
29. Kim TS, Lee KS, Chung MP et al. Nonespecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings. Am J Roentgenol 1998; 171: 1645-1650.
30. Bodolay E, Csipó I, Gal I et al. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. Clin Exp Rheumatol 2004; 22: 409-115.
31. Schimidt K-U, Hartwig M. Are nailfold capillary changes indicators of organ involvement in progressive systemic sclerosis? Dermatologica 1988; 176: 18-21.
32. Joyal F, Choquette D, Roussin A, Levington C, Senecal JL. Evaluation of the severity of systemic sclerosis by nailfold capillaroscopy in 112 patients. Angiology 1992; 43: 203-210.
33. Pucinelli MLC, Atra E, Sato EI, Andrade LEC. Nailfold capillaroscopy in systemic sclerosis: correlations with involvement of lung and esophagus. Rev Bras Reumatol 1995; 35: 136-142.
34. Houtman PM, Kallenberg CGM, Wouda AA, The TH. Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunobiologically mediated local and systemic vascular disease. Ann Rheum Dis 1985; 44: 603-609.
35. Faggioli P, Giani L, Mazzone A. Possible role of iloprost (stable analog of PG12) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 2006; 24: 220-221.
36. Ingegnoli F, Zeni S, Gerloni V, Fantini F. Capillaroscopic observations in childhood rheumatic diseases and healthy controls. Clin Exp Rheumatol 2005; 23: 905-911.